μ-opioid and N-methyl-D-aspartate receptors are localized at laryngeal motoneurons of guinea pigs

Biological and Pharmaceutical Bulletin

Volumn 32, Issue 2, 2009, Pages 293-296

  Yamazaki, Hiromi ^a   Ohi, Yoshiaki ^b   Haji, Akira ^b  

^a UNIVERSITY OF TOYAMA   (Japan)

^b AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

opioid receptor; Guinea pig; Laryngeal motoneuron; N methyl D aspartate receptor

Indexed keywords

MU OPIATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; WHEAT GERM AGGLUTININ;

AMBIGUUS NUCLEUS; ANIMAL TISSUE; ARTICLE; CELL LABELING; COUGHING; GLOTTIS; GUINEA PIG; INNERVATION; MOTONEURON; NONHUMAN; PHENOTYPIC VARIATION; STAINING; SUPERIOR LARYNGEAL NERVE; SYNAPTIC TRANSMISSION;

ANIMALS; FLUORESCENT ANTIBODY TECHNIQUE; GUINEA PIGS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; LARYNGEAL MUSCLES; MOTOR NEURONS; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, OPIOID, MU; WHEAT GERM AGGLUTININS;

EID: 60749135362     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.32.293     Document Type: Article

References (18)

1. Widdicombe J. G., "Handbook of Physiology, The Respiratory System, Control of Breathing," Section 3, Vol. II, Part 1, American Physiological Society, Washington D.C., 1986, pp. 363-394.
2. Sant'Ambrogio G., Kuna S. T., Vanoye C. R., Sant'Ambrogio F. B., Am. J. Resp. Crit. Care Med., 155, 637-641 (1997).
3. Chau T. T., Carter F. E., Harris L. S., J. Pharmacol. Exp. Ther., 226, 108-113 (1983).
4. Ohi Y., Yamazaki H., Takeda R., Haji A., Brain Res., 1021, 119-127 (2004).
5. Ohi Y., Yamazaki H., Takeda R., Haji A., Neurosci Res., 53, 201-209 (2005).
6. Kamei J., Morita K., Saitoh A., Nagase H., Eur. J. Pharmacol., 467, 219-222 (2003).
7. Kamei J., Tanihara H., Igarashi H., Kasuya Y., Eur. J. Pharmacol., 168, 153-158 (1989).
8. Bongianni F., Mutolo D., Nardone F., Pantaleo T., Brain Res., 1056, 145-157 (2005).
9. Mutolo D., Bongianni F., Fontana G. A., Pantaleo T., Brain Res. Bull., 74, 284-293 (2007).
10. Haji A., Ohi Y., Tsunekawa S., Neuropharmacology, 54, 1120-1127 (2008).
11. Reynolds S. M., Mackenze A. J., Spina D., Page C. P., Trends in Pharmacol. Sci., 25, 569-576 (2004).
12. Ruda M., Coulter J. D., Brain Res., 249, 237-246 (1982).
13. Davis P. J., Nail B. S., J. Comp. Neurol., 230, 13-32 (1984).
14. Furusawa K., Yasuda K., Okuda D., Tanaka M., Yamaoka M., J. Comp. Neurol., 375, 147-156 (1996).
15. Takahama K., Shirasaki T., Cough, 3, 1-8 (2007).
16. Bolser D. C., Davenport P. W., Pul. Pharmacol. Tier., 15, 221-225 (2002).
17. Kotzer C. J., Hay D. W. P., Dondio G., Giardina G., Petrillo P., Underwood D. C., J Pharmacol. Exp. Tier., 292, 803-809, (2000).
18. Commons K. G., Van Bockstaele E. J., Pfaff D. W., J. Comp. Neurol., 408, 549-559 (1999).